Atossa Therapeutics
ATOS
ATOS
19 hedge funds and large institutions have $688K invested in Atossa Therapeutics in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.22% more ownership
Funds ownership: 0.17% → 0.39% (+0.22%)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$135K | |
| 2 | +$80K | |
| 3 | +$74K | |
| 4 |
Barclays
London,
United Kingdom
|
+$72K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$48.6K |
Top Sellers
| 1 | -$52K | |
| 2 | -$9.68K | |
| 3 | -$3K | |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$1K |